Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World's Leading International Medical Cannabis Company

About this update from Medipharm Labs Corp.

[{"type":"text","content":"Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company\n\n\n\n TORONTO, June 11, 2025 (GLOBE NEWSWIRE) --\n \n Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3% of the Company’s common stock, today issued a\n \n\n\n\n presentation\n \n\n\n\n to set forth their ambitious plan to grow your investment and help turn MediPharm around.\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Outlines Commitment to Immediately and Aggressively Execute on Action Plan to 10X+ Share Price and Create Value for All Shareholders\n \n\n\n\n\n\n\n\n Details Specific and Measurable Initiatives to Save MediPharm Labs from Insolvency at the Hands of Greedy, Reckless, and Maligned Leaders\n \n\n\n\n\n\n\n\n Sets Forth Plan to Stop Exorbitant Executive Compensation Pay-for-Failure and End 3 Years of Value Destructive Actions\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n THE TIME TO ACT IS NOW. VOTE THE\n \n\n\n\n\n GOLD\n \n\n\n\n\n CARD TODAY.\n \n\n\n\n\n\n SHAREHOLDERS ARE URGED TO PROTECT THEIR INVESTMENT BY VOTING THE\n \n\n\n\n\n GOLD\n \n\n\n\n\n PROXY CARD “FOR” APOLLO CAPITAL’S SIX HIGHLY-QUALIFIED DIRECTOR NOMINEES AND DISREGARD MEDIPHARM LABS’ GREEN PROXY CARD.\n \n\n\n\n\n\n TOGETHER LET’S SAVE MEDIPHARM AND\n \n\n\n\n DELIVER THE VALUE THAT SHAREHOLDERS DESERVE.\n \n\n\n\n\n View the Presentation at\n \n\n\n https://www.curemedipharm.com/historical-filing/investor-presentation\n \n\n\n .\n \n\n\n\n For more information on our detailed value creation plan and instructions on how to vote,\n \n\n please see our website\n \n\n www.curemedipharm.com\n \n .\n \n\n\n Contacts\n \n\n\n For Shareholders:\n \n Carson Proxy\n \n North American Toll-Free Phone: 1-800-530-5189\n \n Local or Text Message: 416-751-2066 (collect calls accepted)\n \n E:\n \n [email protected]\n \n\n\n For Media:\n \n\n [email protected]\n \n\n\n This solicitation is being made by and on behalf of Apollo Capital, who, as of the date of this Circular, beneficial...

More updates from Medipharm Labs Corp.